Daniel Greenleaf's most recent trade in ModivCare Inc was a trade of 26,136 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 8, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ModivCare Inc | Daniel E. Greenleaf | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 26,136 | 26,136 | - | - | Employee Stock Option (Right to Buy) | |
ModivCare Inc | Daniel E. Greenleaf | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 18,340 | 18,340 | - | - | Performance Restricted Stock Units | |
ModivCare Inc | Daniel E. Greenleaf | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 9,170 | 44,248 (0%) | 0% | 0 | Common Stock | |
ModivCare Inc | Daniel Greenleaf | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 172.85 per share. | 15 Sep 2021 | 581 | 35,078 (0%) | 0% | 172.9 | 100,426 | Common Stock |
ModivCare Inc | Daniel Greenleaf | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 178.53 per share. | 13 Feb 2021 | 1,179 | 34,497 (0%) | 0% | 178.5 | 210,487 | Common Stock |
ModivCare Inc | Daniel Greenleaf | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 15,491 | 15,491 | - | - | Employee Stock Option (Right to Buy) | |
ModivCare Inc | Daniel Greenleaf | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.97 per share. | 11 Dec 2020 | 1,457 | 30,934 (0%) | 0% | 143.0 | 208,307 | Common Stock |